The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
 
Employment - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
CRS-207 immunotherapy expressing mesothelin, combined with chemotherapy as treatment for malignant pleural mesothelioma (MPM).
 
Raffit Hassan
Research Funding - Aduro Biotech (Inst); Bayer (Inst); Morphotek (Inst); Roche TCRC (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for MPF assay from Morphotek (approximately $700/year)
 
Evan W. Alley
No Relationships to Disclose
 
Hedy L. Kindler
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Celgene; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; MedImmune; Merck; Plexxikon; Verastem
Research Funding - AB Science; Aduro Biotech; Astellas Pharma; AstraZeneca; Bayer; Celgene; GlaxoSmithKline; Incyte; MedImmune; Merck; Verastem
Expert Testimony - Aduro Biotech
 
Scott Joseph Antonia
Stock and Other Ownership Interests - Cellular Biomedicine Group
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
 
Thierry Marie Jahan
Honoraria - Novartis
Research Funding - Acerta Pharma (Inst); Aduro Biotech (Inst); AstraZeneca/MedImmune (Inst); BIND Therapeutics (Inst); Boehringer Ingelheim (Inst); Golden Biotechnology (Inst); Lilly (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca; Lilly; Novartis
 
Somayeh Honarmand
Employment - Aduro Biotech; Merck (I)
Stock and Other Ownership Interests - Aduro Biotech; Merck (I)
 
Katherine McDougall
Employment - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
 
Chan C. Whiting
No Relationships to Disclose
 
Nitya Nair
No Relationships to Disclose
 
Amanda Enstrom
Employment - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
 
Ed Lemmens
Employment - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
 
Takahiro Tsujikawa
No Relationships to Disclose
 
Sushil Kumar
No Relationships to Disclose
 
Lisa M Coussens
Research Funding - Acerta Pharma; Deciphera; Janssen Research & Development
Other Relationship - Pharmacyclics
 
Aimee Murphy
Employment - Aduro Biotech
Leadership - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
 
Anish Thomas
No Relationships to Disclose
 
Dirk G. Brockstedt
Employment - Aduro Biotech
Leadership - Aduro Biotech
Stock and Other Ownership Interests - Aduro Biotech
Patents, Royalties, Other Intellectual Property - Aduro Biotech